{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:32:09Z","timestamp":1787164329226,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,10]]},"DOI":"10.7759\/cureus.114315","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:38:42Z","timestamp":1786426722000},"source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Performance of AFP, PIVKA-II, and the ASAP Score for Distinguishing Hepatocellular Carcinoma With and Without Portal Vein Tumor Thrombus: A Retrospective Single-Center Study From Pakistan"],"prefix":"10.7759","author":[{"given":"Irtaza","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Ejaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali R","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Babar","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay J","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015, 136:E359-86. 10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability","volume":"19","author":"McGlynn KA","year":"2015","unstructured":"McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015, 19:223-38. 10.1016\/j.cld.2015.01.001","journal-title":"Clin Liver Dis"},{"key":"ref3","unstructured":"Cancer Today. (2022). Accessed. May 2, 2026: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/586-pakistan-fact-."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.32350\/cpr.11.05","article-title":"Current pharmacotherapy trends for hepatitis C in the hospitals of Faisalabad, Pakistan","volume":"1","author":"Fatima M","year":"2023","unstructured":"Fatima M, Habib A, Habib F, et al.. Current pharmacotherapy trends for hepatitis C in the hospitals of Faisalabad, Pakistan. Curr Pharm Res. 2023, 1:70-84. 10.32350\/cpr.11.05","journal-title":"Curr Pharm Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i32.7289","article-title":"Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016","volume":"22","author":"Chan SL","year":"2016","unstructured":"Chan SL, Chong CC, Chan AW, Poon DM, Chok KS. Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016. World J Gastroenterol. 2016, 22:7289-300. 10.3748\/wjg.v22.i32.7289","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S318070","article-title":"Portal vein tumor thrombosis and hepatocellular carcinoma - the changing tides","volume":"8","author":"Khan AR","year":"2021","unstructured":"Khan AR, Wei X, Xu X. Portal vein tumor thrombosis and hepatocellular carcinoma - the changing tides. J Hepatocell Carcinoma. 2021, 8:1089-115. 10.2147\/JHC.S318070","journal-title":"J Hepatocell Carcinoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i31.4360","article-title":"Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: beyond the known frontiers","volume":"25","author":"Cerrito L","year":"2019","unstructured":"Cerrito L, Annicchiarico BE, Iezzi R, Gasbarrini A, Pompili M, Ponziani FR. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: beyond the known frontiers. World J Gastroenterol. 2019, 25:4360-82. 10.3748\/wjg.v25.i31.4360","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i12.3462","article-title":"Management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"Quirk M","year":"2015","unstructured":"Quirk M, Kim YH, Saab S, Lee EW. Management of hepatocellular carcinoma with portal vein thrombosis. World J Gastroenterol. 2015, 21:3462-71. 10.3748\/wjg.v21.i12.3462","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.33393\/jcb.2023.2453","article-title":"PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients","volume":"12","author":"Suttichaimongkol T","year":"2023","unstructured":"Suttichaimongkol T, Mitpracha M, Tangvoraphonkchai K, Sadee P, Sawanyawisuth K, Sukeepaisarnjaroen W. PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. J Circ Biomark. 2023, 12:12-6. 10.33393\/jcb.2023.2453","journal-title":"J Circ Biomark"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25814","article-title":"Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis","volume":"56","author":"Giannini EG","year":"2012","unstructured":"Giannini EG, Marenco S, Borgonovo G, et al.. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology. 2012, 56:1371-9. 10.1002\/hep.25814","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198405313102204","article-title":"Des-\u03b3-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma","volume":"310","author":"Liebman HA","year":"1984","unstructured":"Liebman HA, Furie BC, Tong MJ, et al.. Des-\u03b3-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med. 1984, 310:1427-31. 10.1056\/NEJM198405313102204","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08138-3","article-title":"PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma","volume":"21","author":"Feng H","year":"2021","unstructured":"Feng H, Li B, Li Z, Wei Q, Ren L. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer. 2021, 21:401. 10.1186\/s12885-021-08138-3","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082332","article-title":"Hypermethylation of SCAND3 and Myo1g gene are potential diagnostic biomarkers for hepatocellular carcinoma","volume":"12","author":"Xu F","year":"2020","unstructured":"Xu F, Zhang L, Xu Y, Song D, He W, Ji X, Shao J. Hypermethylation of SCAND3 and Myo1g gene are potential diagnostic biomarkers for hepatocellular carcinoma. Cancers (Basel). 2020, 12:2332. 10.3390\/cancers12082332","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005811","article-title":"Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma","volume":"96","author":"Park SJ","year":"2017","unstructured":"Park SJ, Jang JY, Jeong SW, et al.. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma. Medicine (Baltimore). 2017, 96:e5811. 10.1097\/MD.0000000000005811","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14475","article-title":"The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy","volume":"40","author":"Loglio A","year":"2020","unstructured":"Loglio A, Iavarone M, Facchetti F, et al.. The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy. Liver Int. 2020, 40:1987-96. 10.1111\/liv.14475","journal-title":"Liver Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2023.12.004","article-title":"Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score","volume":"24","author":"Sun LY","year":"2025","unstructured":"Sun LY, Wang NY, Diao YK, et al.. Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score. Hepatobiliary Pancreat Dis Int. 2025, 24:412-22. 10.1016\/j.hbpd.2023.12.004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata M","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, et al.. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017, 11:317-70. 10.1007\/s12072-017-9799-9","journal-title":"Hepatol Int"},{"key":"ref18","article-title":"AJCC Cancer Staging Manual","author":"Amin MB","year":"2017","unstructured":"Amin MB, Edge SB. AJCC Cancer Staging Manual. Springer, Cham, Switzerland; 2017."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491099-diagnostic-performance-of-afp-pivka-ii-and-the-asap-score-for-distinguishing-hepatocellular-carcinoma-with-and-without-portal-vein-tumor-thrombus-a-retrospective-single-center-study-from-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:38:45Z","timestamp":1786426725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491099-diagnostic-performance-of-afp-pivka-ii-and-the-asap-score-for-distinguishing-hepatocellular-carcinoma-with-and-without-portal-vein-tumor-thrombus-a-retrospective-single-center-study-from-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.114315","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}